Growth Metrics

Corcept Therapeutics (CORT) Net Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn -254.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -254.80%
Dec 31, 2025 -21.00%
Sep 30, 2025 -58.37%
Jun 30, 2025 -0.98%
Mar 31, 2025 -26.18%
Dec 31, 2024 -2.06%
Sep 30, 2024 50.56%
Jun 30, 2024 28.94%
Mar 31, 2024 75.53%
Dec 31, 2023 89.07%
Sep 30, 2023 -9.33%
Jun 30, 2023 0.61%
Mar 31, 2023 -30.40%
Dec 31, 2022 -48.18%
Sep 30, 2022 13.45%
Jun 30, 2022 3.16%
Mar 31, 2022 -3.05%
Dec 31, 2021 23.16%
Sep 30, 2021 41.06%
Jun 30, 2021 -6.52%
Mar 31, 2021 -22.00%
Dec 31, 2020 -11.45%
Sep 30, 2020 -17.94%
Jun 30, 2020 40.38%
Mar 31, 2020 64.81%
Dec 31, 2019 33.50%
Sep 30, 2019 48.65%
Jun 30, 2019 11.07%
Mar 31, 2019 4.37%
Dec 31, 2018 -77.62%
Sep 30, 2018 28.87%
Jun 30, 2018 43.88%
Mar 31, 2018 298.56%
Dec 31, 2017 2,039.00%
Sep 30, 2017 432.19%
Jun 30, 2017 1,194.47%
Mar 31, 2017 23,194.74%
Dec 31, 2016 379.35%
Sep 30, 2016 530.12%
Jun 30, 2016 150.46%
Mar 31, 2016 99.61%
Dec 31, 2015 124.62%
Sep 30, 2015 89.99%
Jun 30, 2015 74.36%
Mar 31, 2015 65.33%
Dec 31, 2014 64.99%
Sep 30, 2014 44.93%
Jun 30, 2014 36.52%
Mar 31, 2014 -15.28%
Dec 31, 2013 0.00%
Sep 30, 2013 -31.51%
Jun 30, 2013 -56.60%
Mar 31, 2013 -9.52%
Dec 31, 2012 -11.96%
Sep 30, 2012 -28.87%
Jun 30, 2012 14.47%
Mar 31, 2012 -55.39%
Dec 31, 2011 -40.08%
Sep 30, 2011 9.42%
Jun 30, 2011 -55.96%